Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neobun is an over-the-counter (OTC) topical analgesic plaster originating from Thailand, used for the temporary relief of muscle and joint pain, backaches, arthritis, strains, and sprains. It is available in two main variants: a menthol-based formulation and a capsicum-based formulation. The menthol version typically contains a combination of menthol, methyl salicylate, camphor, and thymol, which act as counter-irritants to provide a cooling sensation and localized analgesia. The capsicum version utilizes capsaicin, which targets TRPV1 receptors to deplete substance P in sensory nerves, thereby reducing pain transmission. These adhesive patches are designed for direct application to the skin, providing sustained delivery of active ingredients to the affected area.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Neobun.